Gut-associated lymphoid tissue (GALT) carcinoma, also termed dome-type carcinoma, is an infrequent distinctive subtype of colorectal adenocarcinoma and only 18 cases have been reported in the English medical literature. These tumors have unique clinicopathological features and are considered to have a low malignant potential with favorable prognosis. Herein, we described a case of a 49-year-old male with intermittent hematochezia for 2 years. Colonoscopy revealed a sessile broad-based polyp of approximately 20 mm × 17 mm in the sigmoid colon 260 mm away from the anus, with a slightly hyperemic surface. Histologically, this lesion showed typical GALT carcinoma. The patient was followed up for one and a half year and he did not experience any discomfort, such as abdominal pain or hematochezia, and no tumor recurrence occurred. Moreover, we reviewed the literature, summarized the clinicopathological features of GALT carcinoma, and highlighted its pathological differential diagnosis to further explore this infrequent type of colorectal adenocarcinoma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/10668969231152582 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Gut-associated lymphoid tissue carcinoma analyzed using next-generation sequencing: A case report.
Pathol Res Pract
November 2024
Department of Pathology, Iwate Medical University School of Medicine, Morioka, Iwate 028-03694, Japan; Department of Pathology, Southern Tohoku Hospital, Koriyama, Fukushima 963-8052, Japan.
Article Synopsis
- GALT carcinomas (GCs) are tumors derived from gut-associated lymphoid tissue, typically appearing as dome-shaped lesions with distinct microscopic features like dilated glands and lymphocyte-rich stroma.
- A case study highlighted a 54-year-old man with a protruding rectal lesion, diagnosed as a GC after surgery, showing atypical tumor characteristics including a lack of common mucin markers.
- Genetic analysis revealed mutations in the EGFR and TP53 genes, differing from standard adenoma-carcinoma mutations, suggesting further investigation is needed to understand the nature and origin of GCs.
Resin-Based 90 Y Tumor Dose as a Predictor of Duration of Response and Survival in Patients With Surgically Unresectable Hepatocellular Carcinoma : A Prospective Single-Arm Study.
Clin Nucl Med
September 2024
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA.
Background: Personalized dosimetry improves overall survival (OS) in patients with hepatocellular carcinoma (HCC) treated with glass 90 Y radioembolization. This study evaluated personalized tumor dose (TD) as a predictor of OS, progression-free survival (PFS), and local duration of response (DOR) in patients with surgically unresectable HCC treated with resin 90 Y radioembolization.
Patients And Methods: This prospective, single-center, single-arm clinical trial (NCT04172714) evaluated the efficacy of scout activity of resin 90 Y versus 99m Tc-MAA for treatment planning.
B cell immune profiles in dysbiotic vermiform appendixes of pancreatic cancer patients.
Front Immunol
December 2023
Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest solid tumors and is resistant to immunotherapy. B cells play an essential role in PDAC progression and immune responses, both locally and systemically. Moreover, increasing evidence suggests that microbial compositions inside the tumor, as well as in the oral cavity and the gut, are important factors in shaping the PDAC immune landscape.
View Article and Find Full Text PDFGut-associated Lymphoid Tissue/Dome-Type Carcinoma of the Colon: A Rare Case Report With Review of the Literature.
Int J Surg Pathol
September 2023
Department of Pathology, Guiqian International General Hospital, Guiyang, Guizhou Province, China.
Gut-associated lymphoid tissue (GALT) carcinoma, also termed dome-type carcinoma, is an infrequent distinctive subtype of colorectal adenocarcinoma and only 18 cases have been reported in the English medical literature. These tumors have unique clinicopathological features and are considered to have a low malignant potential with favorable prognosis. Herein, we described a case of a 49-year-old male with intermittent hematochezia for 2 years.
View Article and Find Full Text PDFVoxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based Y90 radioembolization: a prospective, single-arm study.
Eur J Nucl Med Mol Imaging
May 2023
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA, USA.
Background: There is an increasing body of evidence indicating Y90 dose thresholds for tumor response and treatment-related toxicity. These thresholds are poorly studied in resin Y90, particularly in hepatocellular carcinoma (HCC).
Purpose: To evaluate the efficacy of prospective voxel-based dosimetry for predicting treatment response and adverse events (AEs) in patients with HCC undergoing resin-based Y90 radioembolization.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!